Breaking News

Gilead’s Sovaldi and Harvoni lead the cost parade
Obama administration aims to double investment in antibiotic resistance
‘Culture of blame’ triggers malpractice system
Recombinant factor VIII product treats hemophilia A

Recent Headlines

Public–private collaboration will help Medicare shift to alternative payment models by 2018
Infections cited as primary surgical complications
Blood pressure mortality goes up as deaths from other causes drop


The number of cancer medications approved by the Food and Drug Administration has risen steadily in recent years. This article provides a concise overview of drugs and indications added to the cancer armamentarium in 2014 and to date in 2015.
Taylor Butler PharmD
Stacey Maravent PharmD
Jennifer Boisselle
Jose Valdes PharmD
Prescription: Washington
Sandoz’s Filgrastim Faces Naming and Court Hurdles
As first biosimilar approval nears, key questions remain.
Stephen Barlas